CONTENTS:
- We need better measures to understand the influence of social media on substance use [Editorial]. Riordan B., Scarf D., Strowger M., Alen G., Winter T., Kuntsche E., p. 2162-2164.
- Naloxone dosing in the era of synthetic opioids: Applying the Goldilocks principle [Addiction opinion and debate]. Gonzalez Utrilla M., Chesney E., Neale J., Metrebian N., Kalk N., Skulberg A.K., et al., p. 2165-2172.
- Everything in moderation, even naloxone. Coffin P.O., p. 2173-2174.
- You have to be alive to enjoy the porridge: The role of Goldilocks naloxone dosing in a world of hungry bears. Morgan J.R., Walley A.Y., p. 2175-2176.
- Naloxone dosing: An evolving unregulated drug landscape, care setting considerations, and the need for research. Wong J.S.H., Lau A., Azar P., p. 2177-2178.
- From fairytale to clinical practice: A response to commentaries. Gonzalez Utrilla M., Chesney E., Neale J., Metrebian N., Kalk N., Skulberg A.K., et al., p. 2179-2180.
- Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: A systematic review and meta-analysis. Halicka M., Parkhouse T.L., Webster K., Spiga F., Hines L.A., Freeman T.P., et al., p. 2181-2201.
- Evaluating the impact of vaping facts films on vaping harm perceptions among young adults in the UK: A randomized on-line experiment. Alharbi M., Ward E., Notley C., Dockrell M., Taylor E., East K., p. 2202-2214.
- Changing patterns of nicotine product use and nicotine dependence among United States high-school students: The National Youth Tobacco Survey, 2014-2023. Jackson S.E., Brown J., Tattan-Birch H., Jarvis M.J., p. 2215-2222.
- Transporting the effect of the ASSIST school-based smoking prevention intervention to the Smoking, Drinking and Drug Use Among Young People in England Survey (2004-2021): A secondary analysis of a randomized controlled trial. White J., p. 2223-2230.
- Effectiveness of treating post-traumatic stress disorder in patients with co-occurring substance use disorder with prolonged exposure, eye movement desensitization and reprocessing or imagery rescripting: A randomized controlled trial. Lortye S., Will J.P., Marquenie L.A., Lommerse N.M., Faber N., Goudriaan A.E., et al., p. 2231-2244.
- How changes in post-traumatic stress disorder (PTSD) severity mediate substance use disorder (SUD) severity during and after treatment for co-occurring PTSD and SUD: Results from Project Harmony. Hien D.A., Gette J.A., Blakey S.M., Piccirillo M.L., Back S.E., Bauer A.G., et al., p. 2245-2257.
- Clinical predictors of mortality in dual diagnosis patients receiving integrated in-patient treatment - A cohort study with 21?years follow-up. Düring S.W., Jobe L.B., Balleby M.R., Martensson S., p. 2258-2269.
- Fatal drug overdoses in healthcare workers: A thematic framework analysis of coroner reports. Algahtani T., Gee S., Shah A., Williams B.D., Gorton H.C., Welch S., et al., p. 2270-2281.
- Are cannabis policy changes associated with alcohol use patterns? Evidence for age-group differences based on primary care screening data. Van Doren N., Chi F.W., Young-Wolff K.C., Satre D.D., Sterling S.A., p. 2282-2294.
- Significant changes in preference of illicit drug use in a population of Hanoi, Vietnam-A 6-year wastewater study (2018-2023). Hue T.T.T., Ngo H.K.T., Wang Z., Anh N.T.K., Binh V.N., Trung N.Q., et al., p. 2295-2304.
- Alcohol brief intervention and 2-year healthcare costs: An observational study in adult primary care. Parthasarathy S., Chi F., Sterling S., p. 2305-2318.
- The International Scientific Forum on Alcohol Research (ISFAR) critiques of alcohol research: Promoting health benefits and downplaying harms. Clay J.M., Stockwell T., Golder S., Lawrence K., McCambridge J., Vishnevsky N., et al., p. 2319-2328.
- High potency cannabis flower use is associated with heavier consumption and risk for cannabis use disorder among young adults in California, United States. Dunbar M.S., D'Amico E.J., Seelam R., Davis J.P., Pedersen E.R., Rodriguez A., et al., p. 2329-2334.
- Offering e-cigarettes for smoking cessation and reduction in people with mental illness (ESCAPE): Protocol for a randomized controlled trial. Kale D., Beard E., Ding Y., Pervin J., Wu Q., Arundel C., et al., p. 2335-2347.
- United States trends in non-prescribed use of Adderall and Ritalin: Population Assessment of Tobacco and Health (PATH) Study estimates from 2013 to 2022. Rising J.P., Parks M.J., Han B., Radin R., Mallama C., Kimmel H.L., et al., p. 2348-2354.
- Unreliable evidence from problematic risk of bias assessments: Comment on Begh et al., 'Electronic cigarettes and subsequent cigarette smoking in young people: A systematic review'. Egger S., McKee M., p. 2355-2358.
- Response to comment from Egger and McKee entitled 'Unreliable evidence from problematic risk of bias assessments: Comment on Begh et al., 'Electronic cigarettes and subsequent cigarette smoking in young people: A systematic review"'. Hartmann-Boyce J., Begh R., Conde M., Shahab L., Jackson S.E., Pesko M.F., et al., p. 2359-2360.
- Alcohol labelling and calories, a missed UK public health opportunity. Duncan T., p. 2361-2362.